Evaluation of an intravenous-endovascular strategy in patients with acute proximal middle cerebral artery occlusion

American Journal of Neuroradiology

Volumn 34, Issue 3, 2013, Pages 603-608

  Vendrell, J F ^a   Mernes, R ^a   Nagot, N ^a   Milhaud, D ^a   Lobotesis, K ^a   Costalat, V ^a   Machi, P ^a   Maldonado, I L ^a   Riquelme, C ^a   Arquizan, C ^a   Bonafe, A ^a  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; DRUG EFFICACY; FEMALE; FIBRINOLYTIC THERAPY; HEMATOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MECHANICAL THROMBECTOMY; MIDDLE CEREBRAL ARTERY OCCLUSION; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PATIENT SAFETY; RANKIN SCALE; STROKE PATIENT; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; COMBINED MODALITY THERAPY; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MECHANICAL THROMBOLYSIS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 84876579384     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A3230     Document Type: Article

References (24)

1. Bluhmki E, Chamorro A, Machnig T, et al. Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomized controlled trial. Lancet Neurol 2009;8:1095-102
2. del Zoppo GJ, Poeck K, Pessin MS, et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992;32:78-86
3. Bhatia R, Hill MD, Shobha N, et al. Low ratesof acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action. Stroke 2010;41:2254-58
4. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke: the PROACTIIstudy: arandomized controlled trial-Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003-11
5. Mattle HP, Arnold M, Georgiadis D, et al. Comparison of intraarterial and intravenous thrombolysis for ischemic stroke with hyperdense middle cerebral artery sign. Stroke 2008;39:379-83
6. Sekoranja L, Loulidi J, Yilmaz H, et al. Intravenous versus combined (intravenous and intra-arterial) thrombolysis in acute ischemic stroke: a transcranial color-coded duplex sonography-guided pilot study. Stroke 2006;37:1805-09
7. Rubiera M, Ribo M, Pagola J, et al. Bridging intravenous-intra-arterial rescue strategy increases recanalization and the likelihood of a good outcome in a nonresponder intravenous tissue plasminogen activator-treated patients: a case-control study. Stroke 2011;42:993-97
8. Becktepe JS, You SJ, Berkefeld J, et al. Clinical outcome after mechanical recanalization as mono-or adjunctive therapy in acute stroke: importance of time to recanalization. Cerebrovasc Dis 2011;32:211-18
9. Mazighi M, Serfaty JM, Labreuche J, et al. Comparison of intravenous alteplase with a combined intravenous-endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE) study: a prospective cohort study. Lancet Neurol 2009;8:802-09
10. Shi ZS, Loh Y, Walker G, et al. Endovascular thrombectomy for acute ischemic stroke in failed intravenous tissue plasminogen activator versus non-intravenous tissue plasminogen activator patients: revascularization and outcomes stratified by the site of arterial occlusions. Stroke 2010;41:1185-92
11. Sugiura S, Iwaisako K, Toyota S, et al. Simultaneous treatment with intravenous recombinant tissue plasminogen activator and endovascular therapy for acute ischemic stroke within 3 hours of onset. AJNR Am J Neuroradiol 2008;29:1061-66
12. Tissue plasminogen activator for acute ischemic stroke: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333:1581-87
13. Costalat V, Machi P, Lobotesis K, et al. Rescue, combined, and standalone thrombectomy in the management of large vessel occlusion stroke using the Solitaire device: a prospective 50-patient singlecenter study-timing, safety, and efficacy. Stroke 2011;42:1929-35
14. Nezu T, Koga M, Kimura K, et al. Pretreatment ASPECTS on DWI predicts 3-month outcome following rt-PA: SAMURAI rt-PA registry. Neurology 2010;75:555-61
15. Higashida RT, Furlan AJ, Roberts H, et al, Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology; Technology Assessment Committee of the Society of Interventional Radiology. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 2003;34:109-37
16. The IMS II Trial Investigators. The interventional management of stroke (IMS) II study. Stroke 2007;38:2127-35
17. Nogueira RG, Liebeskind DS, Sung G, et al, for the Multi MERCI Writing Committee. Predictors of good clinical outcomes, mortality, and successful revascularization in patients with acuteischemic stroke undergoing thrombectomy: pooled analysis of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and Multi MERCI trials. Stroke 2009;40:3777-83
18. Penumbra Pivotal Stroke Trial Investigators. The Penumbra Pivotal Stroke Trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009;40:2761-68
19. Hill MD, Rowley HA, Adler F, et al. Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS. Stroke 2003;34:1925-31
20. Molina CA, Alexandrov AV, Demchuk AM, et al. Improving the predictive accuracy of recanalization on stroke outcome in patients treated with tissue plasminogen activator. Stroke 2004;35:151-56
21. Machumpurath B, David SM, Yan B. Rapid neurological recovery after intravenous tissue plasminogen activator in stroke: prognostic factors and outcome. Cerebrovasc Dis 2011;31:278-83
22. Machi P, Costalat V, Lobotesis K, et al. Solitaire FR thrombectomy system: immediate results in 56 consecutive acute ischemic stroke patients. J Neurointerv Surg 2012;4:62-66
23. Castano C, Dorado L, Guerrero C, et al. Mechanical thrombectomy with the Solitaire AB device in large artery occlusions of the anterior circulation: a pilot study. Stroke 2010;41:1836-40
24. Roth C, Papanagiotou P, Behnke S, et al. Stent-assisted mechanical recanalization for treatment of acute intracerebral artery occlusions. Stroke 2010;41:2559-67